Stocks · NASDAQ · Healthcare · United States

RPRX — Royalty Pharma plc

Royalty Pharma plc (RPRX) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 58.22 (-0.26% on the day), -5.2% over one month, +4.8% over three months, +68.4% over twelve months. The InvestMuse composite score is +57 on a −100 to +100 scale, a bullish read that ranks #71 of about 1,221 assets. The strongest of its nine dimensions are Regime (hidden Markov model) (+95) and Fundamentals (+47); the weakest is Trend (-28). Its volatility regime from the hidden Markov model is Cool. 4 news articles in the last 30 days carried an average tone of +0.14 (on −1 to +1).

Open the interactive read →Race RPRX with $100k play money

The facts

Last close58.22 (September 29, 2026)
1 day / 1 month / 3 months / 12 months-0.26% / -5.2% / +4.8% / +68.4%
52-week range34.58 – 63.96
Composite score+57 / 100 · bullish view · rank #71
Volatility regime (HMM)Cool
Support levels26.00, 31.00, 35.00
Trailing P/E38.3
Market cap$31.2B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.